These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1871049)

  • 1. Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF).
    Martinez MN; Jackson AJ
    Pharm Res; 1991 Apr; 8(4):512-7. PubMed ID: 1871049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of truncated areas to measure extent of drug absorption in bioequivalence studies: effects of drug absorption rate and elimination rate variability on this metric.
    Kharidia J; Jackson AJ; Ouderkirk LA
    Pharm Res; 1999 Jan; 16(1):130-4. PubMed ID: 9950291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
    el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R
    Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of truncated area under the curve on failed bioequivalence studies: a computer simulation analysis.
    Mahmood I
    Drug Metabol Drug Interact; 2004; 20(1-2):77-83. PubMed ID: 15283304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials.
    Marzo A; Monti NC; Vuksic D
    Eur J Clin Pharmacol; 1999 Nov; 55(9):627-31. PubMed ID: 10638390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?
    Walter-Sack I; de Vries JX; Kreiner C; Ittensohn A; Stenzhorn G; Voss A; Weber E
    Clin Investig; 1993 Mar; 71(3):240-6. PubMed ID: 8481628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An area correction method to reduce intrasubject variability in bioequivalence studies.
    Abdallah HY
    J Pharm Pharm Sci; 1998; 1(2):60-5. PubMed ID: 10945919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers.
    Huang J; Tian Y; Zhang ZJ; Li J; Cao X
    Arzneimittelforschung; 2011; 61(3):167-72. PubMed ID: 21528641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of long half-life drugs--informative sampling determination--using truncated area in parallel-designed studies for slow sustained-release formulations.
    El-Tahtawy A; Harrison F; Zirkelbach JF; Jackson AJ
    J Pharm Sci; 2012 Nov; 101(11):4337-46. PubMed ID: 22927120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Intra- and Intersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products.
    Sugihara M; Takeuchi S; Sugita M; Higaki K; Kataoka M; Yamashita S
    Mol Pharm; 2015 Dec; 12(12):4405-13. PubMed ID: 26568266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of intestinal expression of P-glycoprotein in healthy volunteers as described by absorption of talinolol from four bioequivalent tablets.
    Siegmund W; Ludwig K; Engel G; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Weitschies W
    J Pharm Sci; 2003 Mar; 92(3):604-10. PubMed ID: 12587122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Truncating AUC at 12, 24 and 48 hr When Evaluating the Bioequivalence of Drugs with a Long Half-Life.
    Moreno I; Ochoa D; Román M; Cabaleiro T; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):53-7. PubMed ID: 26086613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated AUCs in the assessment of the bioequivalence of topiramate, a long half-life drug.
    Almeida S; Spínola AC; Filipe A; Trabelsi F; Farré A
    Arzneimittelforschung; 2007; 57(5):249-53. PubMed ID: 17598694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence study of two minocycline capsule formulations in healthy volunteers.
    Setiawati E; Purnomo A; Deniati SH; Yunaidi DA; Handayani LR; Harinato G; Santoso ID
    Arzneimittelforschung; 2009; 59(10):532-6. PubMed ID: 19998582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.
    Lacey LF; Keene ON; Duquesnoy C; Bye A
    J Pharm Sci; 1994 Feb; 83(2):212-5. PubMed ID: 8169791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
    Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
    Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.